Clinical predictors of depression treatment outcomes in patients with coronary heart disease

被引:14
|
作者
Carney, Robert M. [1 ]
Freedland, Kenneth E. [1 ]
Steinmeyer, Brian C. [1 ]
Rubin, Eugene H. [1 ]
Rich, Michael W. [2 ]
机构
[1] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63108 USA
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA
基金
美国国家卫生研究院;
关键词
Coronary heart disease; Major depression; Treatment; STAR-ASTERISK-D; MYOCARDIAL-INFARCTION; MAJOR DEPRESSION; ARTERY-DISEASE; ANTIDEPRESSANT TREATMENT; CARDIOVASCULAR EVENTS; ENHANCING RECOVERY; TREATMENT RESPONSE; LIFE STRESS; MORTALITY;
D O I
10.1016/j.jpsychores.2016.07.011
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objectives: Patients with coronary heart disease (CHD) who respond to treatment for depression are at lower risk of mortality than are nonresponders. This study sought to determine whether variables that have been shown to predict both depression treatment outcomes in psychiatric patients and cardiac events in patients with CHD, also predict poor response to depression treatment in patients with CHD. Methods: One hundred fifty-seven patients with stable CHD who met the DSM-IV criteria for a major depressive episode were treated with cognitive behavior therapy (CBT) for 16 weeks, either alone or in combination with an antidepressant. Results: The mean Beck Depression Inventory (BDI-II) score was 30.2 +/- 8.5 at baseline and 85 +/- 7.8 at 16 weeks. Over 50% of the participants were in remission (HAM-D-17 score <= 7) at the end of treatment. Of the hypothesized predictors, severe depression at baseline (p = 0.02), stressful life events during the first (p = 0.03) and last (p < 0.0001) 8 weeks of treatment, and the completion of CBT homework assignments (p = 0.001) predicted depression outcomes. History of prior episodes, anxiety symptoms, antidepressant therapy at study enrollment, and medical hospitalizations or emergency department visits during treatment did not predict treatment outcome. Conclusions: Patients who are under considerable stress do not respond as well to evidence-based treatments for depression as do patients with less stress. If future studies support these findings, more work will be needed to better address stressful life events in patients who may otherwise remain at high risk for mortality and medical morbidity following depression treatment. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [21] Exercise and Pharmacological Treatment of Depressive Symptoms in Patients With Coronary Heart Disease
    Blumenthal, James A.
    Sherwood, Andrew
    Babyak, Michael A.
    Watkins, Lana L.
    Smith, Patrick J.
    Hoffman, Benson M.
    O'Hayer, C. Virginia F.
    Mabe, Stephanie
    Johnson, Julie
    Doraiswamy, P. Murali
    Jiang, Wei
    Schocken, Douglas D.
    Hinderliter, Alan L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (12) : 1053 - 1063
  • [22] Depression as a non-causal variable risk marker in coronary heart disease
    Meijer, Anna
    Zuidersma, Marij
    de Jonge, Peter
    BMC MEDICINE, 2013, 11
  • [23] THE CLINICAL PICTURE AND TREATMENT OF DEPRESSION SPECTRUM DISORDERS IN PATIENTS WITH CARDIOVASCULAR DISEASE
    Dovzhenko, T. V.
    Vasyuk, Yu. A.
    Seiniglazova, M. V.
    Krasnov, V. N.
    Lebedev, A. V.
    Tarasova, K. V.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (12) : 30 - 34
  • [24] Long-term cardiac outcomes of depression screening, diagnosis and treatment in patients with acute coronary syndrome: the DEPACS study
    Kim, Jae-Min
    Stewart, Robert
    Kang, Hee-Ju
    Kim, Seon-Young
    Kim, Ju-Wan
    Lee, Hee-Joon
    Lee, Ju-Yeon
    Kim, Sung-Wan
    Shin, Il-Seon
    Kim, Min-Chul
    Shin, Hee-Young
    Hong, Young Joon
    Ahn, Youngkeun
    Jeong, Myung Ho
    Yoon, Jin-Sang
    PSYCHOLOGICAL MEDICINE, 2021, 51 (06) : 964 - 974
  • [25] Inflammation and symptoms of depression and anxiety in patients with acute coronary heart disease
    Steptoe, Andrew
    Wikman, Anna
    Molloy, Gerard J.
    Messerli-Buergy, Nadine
    Kaski, Juan-Carlos
    BRAIN BEHAVIOR AND IMMUNITY, 2013, 31 : 183 - 188
  • [26] Clinical characteristics and outcomes of Chinese patients with coronary heart disease and resistant hypertension
    Zhu, Binbin
    Liu, Yahui
    Zhou, Weicen
    Du, Yao
    Qi, Datun
    Wang, Chenxu
    Cheng, Qianqian
    Zhang, You
    Wang, Shan
    Gao, Chuanyu
    JOURNAL OF CLINICAL HYPERTENSION, 2023, 25 (04): : 350 - 359
  • [27] Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients with coroNary heart Disease (UNWIND) randomized clinical trial
    Blumenthal, James A.
    Feger, Bryan J.
    Smith, Patrick J.
    Watkins, Lana L.
    Jiang, Wei
    Davidson, Jonathan
    Hoffman, Benson M.
    Ashworth, Megan
    Mabe, Stephanie K.
    Babyak, Michael A.
    Kraus, William E.
    Hinderliter, Alan
    Sherwood, Andrew
    AMERICAN HEART JOURNAL, 2016, 176 : 53 - 62
  • [28] Do different depression phenotypes have different risks for recurrent coronary heart disease?
    Shaffer, Jonathan A.
    Whang, William
    Shimbo, Daichi
    Burg, Matthew
    Schwartz, Joseph E.
    Davidson, Karina W.
    HEALTH PSYCHOLOGY REVIEW, 2012, 6 (02) : 165 - 179
  • [29] Diagnosis and treatment of depression following routine screening in patients with coronary heart disease or diabetes: a database cohort study
    Burton, C.
    Simpson, C.
    Anderson, N.
    PSYCHOLOGICAL MEDICINE, 2013, 43 (03) : 529 - 537
  • [30] Depression and Whole Blood Serotonin in Patients With Coronary Heart Disease From the Heart and Soul Study
    Wulsin, Lawson R.
    Musselman, Dominique
    Otte, Christian
    Bruce, Erica
    Ali, Sadia
    Whooley, Mary A.
    PSYCHOSOMATIC MEDICINE, 2009, 71 (03): : 260 - 265